Is it right for me?Updated October 21, 2026

Safety & protocols

Ibogaine is powerful medicine and must be treated with absolute respect. The risks are real, specific, and — in a properly run clinical setting — systematically managed.

A hospital monitor displaying vital signs with a green waveform
Fig. — Continuous cardiac monitoring

The risk, named plainly: ibogaine prolongs the QT interval — the heart's recharge time between beats. In vulnerable people that can trigger dangerous arrhythmias. Documented fatalities cluster around three factors: undetected heart conditions, other drugs still in the system, and settings with no medical screening or monitoring at all.

What proper screening looks like

S·01

12-lead ECG

Read by someone qualified to interpret it — before any dose, no exceptions.

S·02

Blood work

Electrolytes, liver and kidney function — the chemistry that determines how the body handles the dose.

S·03

Full disclosure

Every medication and substance, verified where possible. Screening only protects you if the inputs are true.

S·04

A clinician who can say no

History review by a licensed clinician with authority to reject. A screening process that never rejects anyone is theatre.

What proper supervision looks like

  • Treatment overseen by a licensed physician, supported by nursing staff
  • Continuous cardiac monitoring through the session and beyond it — the metabolite keeps working after the visions end
  • IV access in place, emergency equipment on site, staff trained in resuscitation
  • A realistic plan for reaching a hospital
  • Protocols aligned with GITA guidelines, plus newer cardiac-protective measures such as IV magnesium (used in the 2024 Stanford study)

The one-sentence summary: the danger is concentrated where medicine is absent. Depth is only possible because safety comes first — and a provider who treats screening as a formality has already told you everything you need to know.

Next step

Sources

  • Alper et al. (2012), fatality review, J Forensic Sci · Koenig & Hilber (2015), cardiac pharmacology, Molecules
  • Global Ibogaine Therapy Alliance (2015), Clinical Guidelines for Ibogaine-Assisted Detoxification
  • Cherian et al. (2024), magnesium–ibogaine protocol, Nature Medicine — full analysis in our close read

Wondering if ibogaine fits your situation?

Six questions, two minutes. A straight answer, and we'll tell you honestly if it's no.

Take the screening quiz